Sara Monti

InstitutionRheumatology
AddressLombardia
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 14 Covid-19 publications, with a maximum of 5 publications in April 2020
    All Publications
    Bar chart showing 62 publications over 12 distinct years, with a maximum of 13 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Bugatti S, Balduzzi S, De Stefano L, Manzo A, Xoxi B, Bogliolo L, Monti S, Delvino P, Montecucco C. Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs'. Ann Rheum Dis. 2021 10; 80(10):e156. PMID: 33906858.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    2. Monti S, Bartoletti A, Bellis E, Delvino P, Montecucco C. Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse. Front Med (Lausanne). 2020; 7:589794. PMID: 33364248.
      Citations: 3     
    3. Monti S, Montecucco C. Response to: 'Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic' by Lecler et al. Ann Rheum Dis. 2020 Sep 22. PMID: 32963055.
      Citations:    Fields:    
    4. Favalli EG, Monti S, Ingegnoli F, Balduzzi S, Caporali R, Montecucco C. Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data? Arthritis Rheumatol. 2020 10; 72(10):1600-1606. PMID: 32506699.
      Citations: 34     Fields:    Translation:Humans
    5. Monti S, Montecucco C. Response to: 'Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al. Ann Rheum Dis. 2021 05; 80(5):e68. PMID: 32591359.
      Citations:    Fields:    Translation:Humans
    6. Monti S, Montecucco C. Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak. Ann Rheum Dis. 2020 Jun 05. PMID: 32503855.
      Citations: 1     Fields:    
    7. Monti S, Delvino P, Bellis E, Milanesi A, Brandolino F, Montecucco C. Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis. Ann Rheum Dis. 2020 12; 79(12):1658-1659. PMID: 32448783.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    8. Monti S, Montecucco C. Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al. Ann Rheum Dis. 2021 02; 80(2):e17. PMID: 32434818.
      Citations:    Fields:    Translation:Humans
    9. Monti S, Montecucco C. Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini et al. Ann Rheum Dis. 2021 02; 80(2):e15. PMID: 32414805.
      Citations: 2     Fields:    Translation:Humans
    10. Monti S, Montecucco C. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al. Ann Rheum Dis. 2021 01; 80(1):e11. PMID: 32354773.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    11. Monti S, Montecucco C. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al. Ann Rheum Dis. 2021 02; 80(2):e13. PMID: 32354774.
      Citations:    Fields:    Translation:Humans
    12. Monti S, Montecucco C. The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi et al. Ann Rheum Dis. 2021 01; 80(1):e3. PMID: 32340978.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    13. Monti S, Montecucco C. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit. Ann Rheum Dis. 2020 06; 79(6):e62. PMID: 32327429.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    14. Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020 05; 79(5):667-668. PMID: 32241793.
      Citations: 174     Fields:    Translation:HumansCellsPHPublic Health
    Monti's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (117)
    Explore
    _
    Co-Authors (24)
    Explore
    _
    Similar People (60)
    Explore
    _